Relationship Between Motor and Nonmotor Symptoms and Quality of Life in Patients with Parkinson's Disease

Overview

Journal Nurs Rep

Publisher MDPI

Specialty Nursing

Date 2022 Jan 25

PMID 35076598

Authors

Eduardo Candel-Parra

Maria Pilar Corcoles-Jimenez

Victoria Delicado-Useros

Antonio Hernandez-Martinez

Milagros Molina-Alarcon

Affiliations

Soon will be listed here.

Abstract

Background: Parkinson's disease (PD) is a chronic neurodegenerative disease that implies a progressive and invalidating functional organic disorder, which continues to evolve till the end of life and causes different mental and physical alterations that influence the quality of life of those affected.

Objective: To determine the relationship between motor and nonmotor symptoms and the quality of life of persons with PD.

Methods: An analytic, descriptive, cross-sectional study was conducted with patients with different degrees of PD in the Albacete Health district. The estimated sample size required was 155 patients. The instruments used for data collection included a purpose-designed questionnaire and "Parkinson's Disease Questionnaire" (PDQ-39), which measures eight dimensions and has a global index where a higher score indicates a worse quality of life. A descriptive and bivariate analysis was conducted (SPSS IBM 24.0). Ethical aspects: informed consent and anonymized data.

Results: A strong correlation was found between the number of motor and nonmotor symptoms and global health-related quality of life and the domains mobility, activities of daily living, emotional well-being, cognitive status, and pain ( < 0.05). Receiving pharmacological treatment and taking more than four medicines per day was significantly associated with a worse quality of life ( < 0.05). Patients who had undergone surgical treatment did not show better global quality of life ( = 0.076).

Conclusions: All nonmotor symptoms and polypharmacy were significantly associated with a worse global quality of life.

Citing Articles

Dyskinesia and Pain in Advanced Parkinson's Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study.

Freire-Alvarez E, Vanni P, Kurca E, Lopez-Manzanares L, Kovacs N, Spanaki C Neurol Ther. 2024; 13(2):437-447.

PMID: 38345741 PMC: 10951158. DOI: 10.1007/s40120-024-00583-z.

The Impact of Non-Motor Symptoms on Quality of Life in Cervical Dystonia.

Maione R, Formica C, Quartarone A, Lo Buono V J Clin Med. 2023; 12(14).

PMID: 37510780 PMC: 10380526. DOI: 10.3390/jcm12144663.

References

Alonso Canovas A, Luquin Piudo R, Garcia Ruiz-Espiga P, Burguera J, Campos Arillo V, Castro A . Dopaminergic agonists in Parkinson's disease. Neurologia. 2011; 29(4):230-41. DOI: 10.1016/j.nrl.2011.04.012. View

Schuepbach W, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L . Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med. 2013; 368(7):610-22. DOI: 10.1056/NEJMoa1205158. View

Garcia-Ramos R, Lopez Valdes E, Ballesteros L, Jesus S, Mir P . The social impact of Parkinson's disease in Spain: Report by the Spanish Foundation for the Brain. Neurologia. 2013; 31(6):401-13. DOI: 10.1016/j.nrl.2013.04.008. View

Hassan A, Wu S, Schmidt P, Malaty I, Dai Y, Miyasaki J . What are the issues facing Parkinson's disease patients at ten years of disease and beyond? Data from the NPF-QII study. Parkinsonism Relat Disord. 2012; 18 Suppl 3:S10-4. DOI: 10.1016/j.parkreldis.2012.06.014. View

Martinez-Martin P, Frades Payo B . Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. The Grupo Centro for Study of Movement Disorders. J Neurol. 1998; 245 Suppl 1:S34-8. DOI: 10.1007/pl00007737. View

Prakash K, Nadkarni N, Lye W, Yong M, Tan E . The impact of non-motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study. Eur J Neurol. 2016; 23(5):854-60. DOI: 10.1111/ene.12950. View

DIorio A, Vitale C, Piscopo F, Baiano C, Falanga A, Longo K . Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease. Parkinsonism Relat Disord. 2017; 43:114-117. DOI: 10.1016/j.parkreldis.2017.08.003. View

Rahman S, Griffin H, Quinn N, Jahanshahi M . Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord. 2008; 23(10):1428-34. DOI: 10.1002/mds.21667. View

Monchi O, Hanganu A, Bellec P . Markers of cognitive decline in PD: The case for heterogeneity. Parkinsonism Relat Disord. 2016; 24:8-14. DOI: 10.1016/j.parkreldis.2016.01.002. View

10.

Tu X, Hwang W, Ma H, Chang L, Hsu S . Determinants of generic and specific health-related quality of life in patients with Parkinson's disease. PLoS One. 2017; 12(6):e0178896. PMC: 5484474. DOI: 10.1371/journal.pone.0178896. View

11.

Joseph C, Jonsson-Lecapre J, Wicksell R, Svenningsson P, Franzen E . Pain in persons with mild-moderate Parkinson's disease: a cross-sectional study of pain severity and associated factors. Int J Rehabil Res. 2019; 42(4):371-376. DOI: 10.1097/MRR.0000000000000373. View

12.

Navarta-Sanchez M, Senosiain Garcia J, Riverol M, Ursua Sesma M, Diaz De Cerio Ayesa S, Anaut Bravo S . Factors influencing psychosocial adjustment and quality of life in Parkinson patients and informal caregivers. Qual Life Res. 2016; 25(8):1959-68. PMC: 4945683. DOI: 10.1007/s11136-015-1220-3. View

13.

Benito-Leon J . [Epidemiology of Parkinson's disease in Spain and its contextualisation in the world]. Rev Neurol. 2018; 66(4):125-134. View

14.

HOEHN M, Yahr M . Parkinsonism: onset, progression and mortality. Neurology. 1967; 17(5):427-42. DOI: 10.1212/wnl.17.5.427. View

15.

Martinez-Martin P . What is quality of life and how do we measure it? Relevance to Parkinson's disease and movement disorders. Mov Disord. 2016; 32(3):382-392. DOI: 10.1002/mds.26885. View

16.

Gomez-Esteban J, Tijero B, Somme J, Ciordia R, Berganzo K, Rouco I . Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease. J Neurol. 2010; 258(3):494-9. DOI: 10.1007/s00415-010-5786-y. View

17.

Balestrino R, Martinez-Martin P . Reprint of "Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease". J Neurol Sci. 2017; 374:3-8. DOI: 10.1016/j.jns.2017.01.026. View

18.

Erro R, Picillo M, Vitale C, Amboni M, Moccia M, Santangelo G . The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study. Eur J Neurol. 2016; 23(11):1673-1679. DOI: 10.1111/ene.13106. View

19.

Candel-Parra E, Corcoles-Jimenez M, Delicado-Useros V, Hernandez-Martinez A, Molina-Alarcon M . Evolution of Quality of Life in Persons with Parkinson's Disease: A Prospective Cohort Study. J Clin Med. 2021; 10(9). PMC: 8122703. DOI: 10.3390/jcm10091824. View

20.

von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W . Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol. 2005; 15(4):473-90. DOI: 10.1016/j.euroneuro.2005.04.007. View